March 7, 2002
KPMG Consulting Inc.
Philip A. Garland
Senior Vice President and Life Sciences Segment Leader
Leverage Technical and Business Skills
What is the history of your organization’s involvement in life sciences?
Garland: KPMG Consulting has a well-established life sciences practice that consists of four subsegments: pharmaceutical, biotechnology, medical devices, and medical distributors. What brought us to this market was the desire to leverage our industry knowledge and business systems integration experience in order to provide value and results to our clients. Our approach is to service the life sciences market with a business development and delivery team focused on addressing issues specific to organizations in this industry.
What is your vision for the development of the life sciences market?
Garland: As death rates from causes such as war, natural disaster, etc., continue to decline, birthrates stabilize, and infant mortality rates decrease, the quality and availability of healthcare will increasingly become a determining factor in life expectancy. I believe that life sciences companies play a pivotal role in terms of disease prevention, treatment, and cure as well as elevating the quality of life and extending life span. I’ve also seen many studies that reveal that utilizing more and better diagnostics, drugs and devices can reduce overall healthcare costs.
So, in my opinion, product development is crucial to any long-term vision of affordable healthcare. If we can think in terms of appropriate life-stage disease prevention and treatment programs being be available to everyone, we can all have an equal opportunity for a long and healthy life. At KPMG Consulting, we aspire to leverage our technical and business skills with the belief that if we can improve the financial performance of Life Sciences companies this will ultimately translate into more R&D investment and hence better and more effective drugs available to a broader spectrum of people.
What organizational assets have you developed to serve this community?
Garland: As a services firm, our organizational assets are our people. Our consultants average 13.5 years of industry experience and our Life Sciences practice includes industry experts with backgrounds ranging from research and development and production to sales and marketing. Through our extensive training program, we expand the knowledge and capabilities of the individuals in our practice on an ongoing basis to address specific industry needs.
What products and services does your company provide to the life sciences market?
Garland: KPMG Consulting offers services across eight major solutions areas. Our life sciences practice tailors each of these solution areas to address the specific needs of the industry. Our solutions include: strategy and business architecture; customer relationship management (CRM); supply chain management; enterprise solutions; wireless solutions; integration solutions; infrastructure solutions; and managed services.
We have also made significant investments to develop new solutions specific to the life sciences industry, including 21 CFR part 11 compliance, clinical trials supply chain management, campaign management, connect-to-customer pharma, Siebel pharma, and SAP pharma.
These solutions are developed and displayed in our life sciences development and demonstration centers. Building upon our broadband solutions center infrastructure, we offer clients a new kind of value to help them compete in a market where speed of development and deployment of technology solutions are essential to success. Our centers provide a world-class broadband development and testing environment that allows clients to jump-start new projects, reduce the impact on current operations, and mitigate risk in implementing new technologies into their existing systems.
Return to main index page.